According to a new market research report from MarketsandMarkets, the global home healthcare market is expected to reach USD 365 Billion by 2022 growing at a CAGR of 8.8 from 2017 to 2012. Testing, screening, and monitoring devices are expected to dominate the market due to emphasis on diseases prevention and technological advancements. “The Dianax mobile lab-on-a-chip device has been designed to bring diagnostics testing, screening and monitoring directly into patient homes and to patients wherever they may be. It empowers patients to take a more active role in their care.” says Pascal Pouligny, Chief Marketing Officer. “We are seeing a tectonic shift in healthcare infrastructure as we know it, powered by the smartphone revolution, and Dianax is at the cutting-edge of mobile diagnostic transformation. It is our belief that rapid detection combined with informed decision-making will optimize treatment and improve patient outcomes. Whether it be expediting the screening, diagnosis and management of chronic diseases such as diabetes or anemia or the next global outbreak of infectious disease, Dianax aims to provide fast, reliable and affordable diagnostics at the point of need – anywhere, anytime and for anyone.”